AAVogen

    OverviewSuggest Edit

    AAVogen is a company that develops gene therapeutics for muscle wasting diseases. It offers AVGN7 to treat inclusion body myositis, cancer cachexia, and Duchenne muscular dystrophy.
    TypePrivate
    Founded2015
    Websiteaavogen.com

    Latest Updates

    Employees (est.) (Apr 2020)2

    AAVogen Financials and Metrics

    Summary Metrics

    Founding Date

    2015
    Show all financial metrics

    AAVogen Online and Social Media Presence

    Embed Graph

    AAVogen Frequently Asked Questions

    • When was AAVogen founded?

      AAVogen was founded in 2015.

    • How many employees does AAVogen have?

      AAVogen has 2 employees.

    • Who are AAVogen competitors?

      Competitors of AAVogen include CytomX Therapeutics, Calithera Biosciences and TESARO.